Archive: 07/08/2014

Dimethyl fumarate for MS: Added benefit is not proven

Dimethyl fumarate (trade name: Tecfidera) has been approved since January 2014 for adults with relapsing remitting multiple sclerosis (RRMS). In an early benefit assessment pursuant to the Act on the Reform of the Market ...

Researchers develop new tool to prevent heroin deaths

A new, lifesaving product aimed at reducing the death toll from heroin abuse—developed by a professor at the University of Kentucky College of Pharmacy—is in its final round of clinical trials and has received Fast Track ...

page 4 from 9